No Data
No Data
Form 8.5 (EPT/RI)-Renalytix Plc
Renalytix AI Reduces Debt With New Share Issue
Renalytix RNLX Steno Deal; CNS Pharmaceuticals CNSP NASDAQ Compliance
H.C. Wainwright Maintains Renalytix(RNLX.US) With Buy Rating, Maintains Target Price $3
Renalytix Price Target Maintained With a $3.00/Share by HC Wainwright & Co.
Buy Rating Justified by Renalytix AI's European Expansion and Positive Medicare Coverage